BCAX
Bicara Therapeutics

69
Loading...
Loading...
News
all
press releases
News Placeholder
Does Bicara Therapeutics Inc. (BCAX) Have the Potential to Rally 187.73% as Wall Street Analysts Expect?
The consensus price target hints at an 187.7% upside potential for Bicara Therapeutics Inc. (BCAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·25d ago

Latest BCAX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.